{"page_content": "41\nESG R eport 2022\nAgios  Awards\n2021\nTOP 100\nWomen-Led Business\nCOMMONWEAL TH  \nINSTITUTE2021  \nGallagher\nBest-in-Class  \nEMPLOYER FOR  \nEMPLOYEE BENEFITS\nBarron \u2019s\nTOP 100\nSUSTAINABLE  \nCOMPANIES  \n20202014 \nWorld Economic Forum\nTechnology  \nPioneerFierceBiotech \u2019s \n2009  \nFierce 152020 \nWomen on Boards \n\u201cW\u201d  \nWINNING COMPANY\nNew England  \nVenture  \nCapital Association\u2019s 2018  \nNEVY Awards\nPATIENT IMPACT  \nAWARDFinalist 2021  \nCiteline Award for\nExcellence in  \nRare Disease Drug \nDevelopment\nBARRON\u2019S", "metadata": {"source": "NASDAQ_AGIO_2021.pdf", "page": 40, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}